Patient Advocates Enlist Senate In Fighting TPP Drug Pricing Provisions

U.S. patient advocate groups and labor unions are ratcheting up their effort to convince the Obama administration to back away from provisions it has proposed in the Trans-Pacific Partnership (TPP) negotiations that the groups fear could help multinational drug companies drive up pharmaceutical prices under public health programs in the United States. These groups -- which include the American Association of Retired Persons (AARP) and the American Federation of State, County and Municipal Employees (AFSCME) -- are urging senators to...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.